Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Samuel J Hong"'
Autor:
Federico Felizzi, Samuel J Hong, Ibou Dieye, Anthony Masaquel, Keith A. Betts, Mathias Schulz, Jia Li
Publikováno v:
Blood. 136:3-3
Introduction Polatuzumab vedotin (pola), a first-in-class CD79b-targeted antibody-drug conjugate, was recently approved by the United States (US) Food and Drug Administration (June 2019) in combination with bendamustine-rituximab (BR) for the treatme